SR-17018, sometimes shortened to SR-17, is an experimental opioid. It was developed in a lab to see whether a painkiller could work like morphine without the worst side effects. It was never approved as a medicine, but it has turned up for sale online as a research chemical.
Ahead, we explain what it is, what is known about its effects and risks, and what withdrawal can look like.
What Is SR-17?
Scripps Research Institute originally made SR-17 (short for SR-17018) as a safer opioid. It’s not found in nature or related to plants like kratom. It’s a lab-made compound that acts on the same brain system as heroin, fentanyl, and prescription pain relievers.
Like other opioids, it stimulates the mu-opioid receptor (also written μ-opioid receptor or MOR). These receptors sit on nerve cells in the brain, spinal cord, and gut. When activated, they block pain signals and produce other effects, like euphoria and sedation.
Drugs that switch this receptor on are called mu-opioid receptor agonists (or μ-opioid receptor agonists). That group includes morphine, oxycodone, methadone, heroin, and fentanyl.
How It Works
When a drug binds to the mu-opioid receptor, the receptor can send signals down more than one path. There are two crucial paths here:
- G protein signaling, which is linked to pain relief.
- Beta-arrestin signaling, which was long blamed for some side effects, including slowed breathing and constipation.
A biased agonist is a drug built to push the receptor toward one path more than the other. SR-17018 was described as a G protein-biased compound, meaning it favored G protein signaling and left beta-arrestin mostly alone.
The goal was to keep the pain relief while cutting out the risks. That would mean a wider therapeutic window, the gap between a safe dose and a harmful dose.
Early tests measured how strongly SR-17018 switched on G proteins in cells (GTPγS binding). It looked like a G protein-biased compound, so the theory made total sense.
The Limitations
Almost everything we know about SR-17018 comes from mouse models of pain, not human research. The hot plate test, for instance, measured how long it took a mouse to react to a warm surface. A longer delay meant the drug was blocking pain, what scientists call antinociception.
In these experiments, SR-17018 reduced pain responses. Some noteworthy findings:
- It caused less slowed breathing than morphine at doses that gave equal pain relief.
- Mice built up a tolerance to it more slowly.
- It eased morphine withdrawal in mice that were already hooked on morphine.
And when people saw “eases opioid withdrawal,” they thought it was an instant fix. But without human clinical trials:
- You can’t be sure it will actually work the same way in people.
- There’s no known safe dose.
- Nobody knows the long-term side effects or risks.
- Products sold as SR-17018 may not contain what the label says.
- Reported benefits like pain relief and body relaxation are purely anecdotal.
Health Risks and Possible Side Effects
The main issue with SR-17018 is the lack of reliable human safety data. Something that can look promising in animal tests can still be really dangerous for people.
Respiratory Depression and Overdose
These are major concerns. Opioids can slow your breathing until your body doesn’t get enough oxygen, leading to brain damage or a fatal overdose if you stop breathing altogether.
Early tests suggested SR-17018 slowed breathing less than morphine. However, fewer or milder side effects in an animal study don’t mean it’s safe for people.
Mixing an experimental opioid with alcohol, benzodiazepines, sleeping medications, or other sedatives only increases the risk of dangerous breathing problems.
Opioid-Related Effects
Since SR-17018 is a synthetic opioid, these are potential side effects you might expect:
- Drowsiness and reduced alertness
- Dizziness and impaired coordination
- Nausea and vomiting
- Constipation
- Confusion or reduced awareness
- Slowed breathing and loss of consciousness
Note that this is not a confirmed list of SR-17018 side effects in humans.
Dependence and Addiction
The mu-opioid receptor adapts to repeated exposure. The body gets used to the drug, which is how physical dependence forms. Some people also develop opioid use disorder, a pattern of compulsive use despite harm.
A drug can cause physical dependence without the person having a use disorder, but both are possible with SR-17018. Nothing in the research says it is exempt, and the mouse studies actually involved withdrawal and dependence in the first place.
SR-17018 Withdrawal
We don’t have any human data on SR-17018 withdrawal specifically. However, if using it repeatedly leads to physical dependence, stopping it could easily trigger standard opioid withdrawal.
Withdrawal symptoms associated with established opioids include:
- Muscle and bone aches
- Sweating, chills, and goosebumps
- Runny nose, watery eyes, and yawning
- Nausea, vomiting, and diarrhea
- Anxiety, restlessness, and trouble sleeping
- Strong cravings
Morphine withdrawal is the textbook example. While rarely fatal on its own, it’s miserable. The bigger danger actually comes after withdrawal. By this time, your tolerance drops, meaning returning to an old dose can cause a fatal overdose.
Quitting an opioid cold turkey on your own is hard and risky. Medical professionals use medication-assisted treatment, typically involving buprenorphine, methadone, or naltrexone, to keep withdrawal and cravings manageable.
SR-17018 vs Other Opioids
Morphine and oxycodone are standard prescription pain medicines. Methadone is used to treat both pain and opioid addiction, while buprenorphine is commonly used for pain and addiction recovery. Doctors know how to use these medicines safely, even though they still carry risks.
Oliceridine is another opioid medicine created for acute pain. Like SR-17018, researchers designed it around targeted receptor signaling, but it’s a different drug with its own clinical testing and safety record.
Kratom is also sometimes mentioned in discussions about opioid-like effects, but it contains different active compounds and is not equivalent to SR-17018.
Other street or synthetic opioids, like brorphine and nitazenes, fall into a broad category of novel compounds. Both are more potent than morphine and are banned in the US.
Is SR-17018 Legal?
The DEA temporarily placed SR-17018, or 5,6-Dichloro Desmethylchlorphine, in Schedule I in August 2026. That means it’s illegal to buy, sell, or possess under federal law. Keep in mind, though, that a Schedule I classification is a legal status, not a complete scientific measurement of how toxic a chemical is.
You might see technical codes on a website, like an InChI identifier or a SMILES string, that describe its chemical layout. However, they don’t prove that what’s inside a product bought online is pure, accurate, or safe.
Calling something a “research chemical” just means it was made for lab experiments, not medical treatment. That label isn’t a badge of quality.
Frequently Asked Questions
Is SR-17018 an opioid?
Yes. It acts on the mu-opioid receptor, the same target as morphine, oxycodone, and fentanyl. It was designed to behave differently at that receptor, but it is still an opioid.
Is SR-17018 safe?
No, SR-17018 cannot be considered safe. It’s an experimental research chemical with no completed human clinical trials evaluating its safe dosage, side effects, or long-term risks.
Can you become dependent on SR-17018?
Probably, but there’s no human data either way. It acts on the same receptor as other opioids, and repeated exposure to that receptor is what leads to dependence.
Can SR-17018 help with opioid withdrawal?
Mouse studies showed it reduced morphine withdrawal signs, and some people in a self-report study described milder withdrawal while using it. However, neither proves the compound works or is safe.
Does SR-17018 show up on a drug test?
Regular drug tests usually only look for common opioids like morphine. SR-17018 is built differently, so a normal drug screen won’t pick it up. Even specialized tests for fentanyl, methadone, or buprenorphine won’t detect it.
Labs can run more advanced tests, like liquid chromatography with mass spectrometry, that can find almost any substance if they know to look for it.
Can naloxone reverse an SR-17018 overdose?
It probably can, since SR-17018 acts on the same receptor naloxone blocks. But this hasn’t been well studied in humans. More than one dose may be needed, and you still have to call emergency services.
Is it safe to mix SR-17018 with other drugs?
SR-17018 has never been tested in people, so nobody knows how it reacts with other drugs. But remember, mixing any opioid with alcohol, sleeping pills, or anxiety meds is one of the biggest causes of deadly overdoses because they all slow your breathing.
Can you buy SR-17018 online?
You can buy research chemicals like SR-17018 online, but they’re strictly sold for lab use, not for people to take. Products sold in these grey-market corners of the internet aren’t regulated, so there’s no way to know what’s actually in them or how strong they are.
The Bottom Line
SR-17018 is a real piece of pain research. It showed that scientists might be able to tweak how opioid receptors work in the body.
People struggling with opioid dependence claimed it helped them, but those are personal stories, not hard scientific proof. Right now, it’s still just a lab chemical tested on mice, with no official human studies to back it up.
Anyone using it, or thinking about it as a way through withdrawal, takes on the risks of any opioid plus a lot of unknowns. If you or someone you know is struggling with opioids, talk to an addiction specialist who can offer treatment options that have actually been tested in people.
Written by: The Garden State Detox Editorial Team
Published on: November 9, 2026
Updated on: November 9, 2026
